Health Data and HIPAA: Where Business Needs Meet the Privacy Rule
Overcoming Compliance Challenges Using Data in Research, Artificial Intelligence, Commercialization
A live 90-minute CLE video webinar with interactive Q&A
This CLE webinar will provide a comprehensive overview of the permissible uses of health data for expansive business needs including research, artificial intelligence development, and commercial purposes under the HIPAA privacy rule. The panel will discuss the circumstances under which health data is considered protected health information (PHI) subject to the privacy rule and the requirements for using the data for these purposes. The panel will also offer best practices for remaining HIPAA compliant while meeting business needs.
Outline
- Introduction
- PHI overview
- Required vs. permissible PHI disclosures under HIPAA
- Permitted uses of PHI under HIPAA
- Research purposes
- Artificial intelligence development
- Commercialization/marketing
- De-identified health information
- Other
- Other federal and state privacy pointers
- Practitioner takeaways
Benefits
The panel will review these and other important considerations:
- What are permissible uses of health data in research activity under HIPAA?
- What challenges face covered entities when using health data for developing artificial intelligence?
- Under what circumstances may health data be used for commercial purposes?
- What other privacy considerations on the federal and state level outside of HIPAA should counsel be aware of?
Faculty
Erica L. Reagan
Attorney
Polsinelli
Ms. Reagan’s practice bridges FDA and healthcare enabling her to provide comprehensive, effective, and innovative... | Read More
Ms. Reagan’s practice bridges FDA and healthcare enabling her to provide comprehensive, effective, and innovative legal solutions. She has developed a broad range of regulatory experience, representing clients in complex regulatory and administrative issues including navigating regulatory and policy matters involving the FDA and FTC; assisting parties in transactions based upon FDA-regulated products, including mitigation of FTC inquiries and other compliance challenges; counseling on advertising and promotional related issues and assisting clients in engaging with the regulatory process through federal submissions; structuring health care arrangements, including equity and asset purchases of pharmacies, home health agencies, hospices, and laboratories; counseling health care entities regarding reports to the National Practitioner Data Bank and state licensing boards; and assisting in responding to government or private contract inquiries, suspensions, or terminations of facility/individual enrollment or licensure.
Close
Shalyn Watkins
Attorney
Holland & Knight
Ms. Watkins represents various healthcare providers and companies, including, but not limited to, individual... | Read More
Ms. Watkins represents various healthcare providers and companies, including, but not limited to, individual providers and provider practices, long-term care and skilled nursing facilities, laboratories, technology companies, and insurers and health plans. Ms. Watkins also assists clients with developing and managing compliant healthcare programs. Her practice involves assisting clients with regulatory compliance, health information privacy advising, Medicare and Medicaid/Medi-Cal reimbursement and overpayment issues, licensure and credentialing disputes, and transaction due diligence and structuring. Ms. Watkins experience includes knowledge of the Health Insurance Portability and Accountability Act (HIPAA), corporate practice of medicine, Stark Law, Anti-Kickback Statute (AKS), Eliminating Kickbacks in Recovery Act (EKRA), contract disputes, administrative law and regulatory enforcement actions, compensation and policy reviews, and the development and implementation of compliance plans for clients.
Close